Why Are Women with High FSH Being Still Told IVF Is Your Only Option?
Why Are Women With High FSH Still Being Told IVF Is Their Only Option?
If you’ve been told your high FSH means IVF is your only path forward, it may be time to ask a different question: is that really the only option, or is it just the most familiar one in mainstream fertility care? Dr. Jerome Check’s work offers a very different lens, one that suggests some women with high FSH, diminished ovarian reserve, or even apparent premature ovarian failure may still have meaningful options that do not begin with “more stimulation” and do not automatically end with donor eggs.
The story most women are told
For many women, the conversation goes like this: your FSH is high, your AMH is low, your egg reserve is poor, and IVF is your best, or only chance. That message has been reinforced by influential IVF data, including one major report showing no live births in women who had ever recorded a day-3 FSH of 18 mIU/mL or higher despite transfer of morphologically normal embryos.
The problem is that this can quickly become a blanket narrative. High FSH gets treated like a final verdict instead of one piece of a much more complicated fertility picture.
What FSH actually does
In plain English, FSH is a hormone made by the brain that tells the ovary to grow a follicle and help an egg mature. It is basically a growth signal.
But FSH only works if it can bind to FSH receptors on the cells surrounding the follicle, called granulosa cells. Those receptors matter because they are the part of the ovarian cell that “hears” and responds to the message.
So if FSH is the message, the receptors are the ears.
Why the receptors matter so much
Check’s central idea is simple but powerful: sometimes the problem is not just low egg reserve, but low ovarian responsiveness because the receptors are no longer available on the cell surface.
According to his model, when FSH stays high for too long, the ovary protects itself by pulling those receptors inward, a process called receptor down-regulation or internalization. Once that happens, the ovary becomes less sensitive to FSH. It can’t hear the signals anymore. That means a woman can have a very high FSH level in her bloodstream, yet her follicles may not be responding well because they are not “hearing” it. In that setting, simply adding more FSH through aggressive stimulation may not help, and may even make the down-regulation worse.
Why estrogen becomes the answer
This is where Check’s work gets so innovative. Instead of assuming the ovary needs more FSH, he asked whether the ovary first needed help becoming sensitive to FSH again.
Estrogen naturally feeds back to the pituitary and lowers FSH production. Check used that on purpose: by giving estrogen, and later ethinyl estradiol, he aimed to bring FSH down first so the FSH receptors could return to the cell surface and become responsive again.
So in plain English:
· FSH is the message.
· The receptors are the ears.
· Estrogen turns the noise down so the ears can work again.
That is the key shift. Instead of shouting louder at the ovary, his protocol tries to make the ovary able to listen again.
The early case studies that changed the conversation
In a 1984 report, Check treated 5 women under 35 who had hypergonadotropic amenorrhea - meaning no periods, very low estrogen, and high FSH, a combination usually interpreted as premature ovarian failure with poor fertility prospects.
He first used conjugated estrogens to suppress FSH, then added human menopausal gonadotropin (hMG) to stimulate ovulation. Three of the five women ovulated, and two conceived after having previously looked like extremely poor candidates for success.
One woman had an FSH that rose from 39.2 to 52 mIU/mL and had already failed to respond to hMG alone, but after estrogen lowered her FSH to 10 mIU/mL, she developed mature follicles and conceived in the next treatment cycle. Another woman with marked estrogen deficiency and FSH averaging 65.4 mIU/mL eventually conceived after repeated ovulatory cycles once estrogen had lowered FSH and restored responsiveness.
That is a profoundly different story from “your ovaries are done.”
The larger series that adds real hope
Dr. Check did not stop with a few case reports. He later reported on 100 consecutive women with hypergonadotropic amenorrhea, ages 19 to 47, treated with this FSH receptor up-regulation approach. Across 561 treatment attempts, there were 68 ovulations, and the clinical pregnancy rate per successful ovulation was 28 percent, although about half of those pregnancies miscarried. These were women many clinics would have viewed as having ovarian failure, yet ovulation and pregnancy still occurred in a meaningful number of cases.
That does not mean the road was easy. It does mean that “failure” was not always final.
The case studies that make people stop and reread
Some of Check’s later reports are the kinds of cases that challenge almost everything women are routinely told.
He cites a case of successful pregnancy in a 25-year-old woman with apparent premature ovarian failure and an FSH as high as 164 mIU/mL. He also describes a woman with 6 years of amenorrhea, estradiol of 15 pg/mL, and FSH of 143 mIU/mL at his clinic, later found to have been as high as 185 mIU/mL elsewhere who ovulated after treatment with ethinyl estradiol alone and conceived with her own egg despite previously failing four donor-egg IVF cycles at another center.
He further references published success in a 45-year-old woman who appeared to be in overt menopause and a 46.5-year-old woman in overt menopause who achieved a live birth after follicular sensitivity to FSH was restored using ethinyl estradiol-based treatment. These are exceptional cases, not guarantees, but they are powerful reminders that “menopausal labs” do not always mean zero possibility.
Why are women still being told IVF is the only way?
There are a few reasons this keeps happening.
First, IVF is the dominant fertility framework, and it is standardized, scalable, and familiar. Second, many clinics are trained to respond to poor ovarian reserve with stronger stimulation, not with receptor-focused hormone modulation. Third, if the most visible data come from women who did poorly under high-dose IVF stimulation, it becomes easy to conclude that the woman cannot succeed - when the more accurate conclusion may be that she did poorly under that particular protocol.
Check’s work raises a different possibility: maybe some women with high FSH are not unreachable, but simply being treated in a way that makes a resistant ovary even more resistant.
What this means for women reading this
This does not mean IVF is never helpful. It does not mean every woman with high FSH can conceive naturally or with gentle treatment. And it does not mean these protocols are simple enough to try without an experienced physician.
But it does mean women deserve more than an automatic script. They deserve to know that there is published work suggesting other biologic explanations, other treatment ideas, and real case studies showing that high FSH is not always the end of the story. This is how restorative reproductive medicine works.
Women also deserve better questions, such as:
· Are we trying to restore FSH receptor sensitivity, or just increase stimulation?
· Could estrogen or ethinyl estradiol be used to lower FSH first in a carefully monitored way?
· Is IVF being recommended because it is truly the only path, or because it is the most familiar path?
A more hopeful ending
One of the most hopeful parts of Check’s work is not that it promises miracles. It is that it refuses to reduce a woman’s future to one lab value.
A high FSH number may signal a serious challenge. But in Check’s published research and case studies, it did not always mean hopeless, and it did not always mean IVF was the only way forward.
Sometimes the issue was not that the ovary had nothing left to offer. Sometimes the issue was that the signal had stopped being heard, and estrogen, used strategically, helped the ovary listen again.
Tracy
https://blog.tracydonegan.org/blog/donor-eggs-increased-pregancy-complications
https://blog.tracydonegan.org/blog/low-amh-high-fsh-donor-eggs-what-ivf-clinic-data-shows
https://blog.tracydonegan.org/blog/the-shadow-costs-of-ivf-what-you-dont-know-can-hurt-you
